Baroda BNP Paribas Manufacturing Fund
(An open-ended equity scheme predominantly
investing in Manufacturing theme)
Baroda BNP Paribas Manufacturing Fund
(An open-ended equity scheme predominantly
investing in Manufacturing theme)
July 2026

July 2026


Investment Objective

The investment objective is to generate long-term capital appreciation from a portfolio invested predominantly in equity and equity related securities of companies engaged in the Manufacturing. The Scheme does not guarantee/indicate any returns. There is no assurance that the investment objective of the Scheme will be achieved.

NAV Details (As on July 31, 2026)
Regular IDCW : ₹ 11.0482
Regular Growth : ₹ 11.0482
Direct IDCW : ₹ 11.3716
Direct Growth : ₹ 11.3716
 
Benchmark Index (AMFI Tier 1)

Nifty India Manufacturing TRI

Date of Allotment

June 28, 2024

Fund Manager
Fund Manager Managing fund since Experience
Mr. Kushant Arora 21-Oct-24 11 years
Mr. Himanshu Singh# 01-Jul-26 10 years
#Mr. Himanshu Singh was appointed as Fund Manager w.e.f July 1, 2026 in place of Mr. Jitendra Sriram.
Load Structure

Exit Load: • If units of the Scheme are redeemed or switched out up to 10% of the units within 1 year from the date of allotment - Nil. • If units of the scheme are redeemed or switched out in excess of the limit within 1 year from the date of allotment - 1% of the applicable NAV. • If units of scheme are redeemed or switched out after 1 year from the date of allotment - Nil

For detailed load structure please refer Scheme Information Document.

Lumpsum Details

Minimum Amount: Lumpsum investment:
₹ 1,000 and in multiples of ₹ 1 thereafter.
Minimum Additional Application Amount:₹ 1,000 and in multiples of ₹ 1 thereafter.


Monthly AAUM## As on July 31, 2026 : ₹ 843.91 Crores
AUM## As on July 31, 2026 : ₹ 846.24 Crores

## including inter-scheme Investments, if any, by other schemes of Baroda BNP Paribas Mutual Fund, as may be applicable

EQUITY HOLDINGS % of Net Assets
Pharmaceuticals & Biotechnology 16.49%
Divi's Laboratories Limited 6.81%
Sun Pharmaceutical Industries Limited 4.87%
AstraZeneca Pharma India Limited 2.24%
IPCA Laboratories Limited 1.67%
Pfizer Limited 0.90%
Electrical Equipment 14.47%
Hitachi Energy India Limited 6.08%
Bharat Heavy Electricals Limited 5.19%
ABB India Limited 1.94%
Siemens Energy India Limited 1.26%
Automobiles 11.53%
Mahindra & Mahindra Limited 3.43%
TVS Motor Company Limited 3.16%
Maruti Suzuki India Limited 3.03%
Hero MotoCorp Limited 1.91%
Non Ferrous Metals 9.02%
Vedanta Aluminium Metal Limited 3.28%
National Aluminium Company Limited 2.98%
Hindustan Zinc Limited 2.76%
Auto Components 8.94%
ZF Commercial Vehicle Control Systems India Limited 2.16%
Bharat Forge Limited 2.11%
Bosch Limited 1.97%
Jtekt India Limited 1.38%
Tenneco Clean Air India Limited 1.32%
Chemicals & Petrochemicals 5.78%
Linde India Limited 2.65%
Navin Fluorine International Limited 1.93%
Pidilite Industries Limited 1.20%
Petroleum Products 5.32%
Reliance Industries Limited 5.32%
Agricultural, Commercial & Construction Vehicles 3.99%
Tata Motors Ltd 1.67%
Escorts Kubota Limited 1.39%
BEML Limited 0.93%
Aerospace & Defense 3.01%
Bharat Electronics Limited 1.65%
Aequs Limited 1.36%
Fertilizers & Agrochemicals 2.71%
Sumitomo Chemical India Limited 2.71%
Ferrous Metals 2.70%
JSW Steel Limited 2.70%
Industrial Products 2.35%
Cummins India Limited 2.35%
Cement & Cement Products 1.98%
The India Cements Limited 0.99%
JSW Cement Limited 0.99%
Power 1.90%
NLC India Limited 1.90%
Consumer Durables 1.41%
LG Electronics India Ltd 1.41%
Oil 1.27%
Oil India Limited 1.27%
Diversified 1.18%
3M India Limited 1.18%
Industrial Manufacturing 0.98%
Cochin Shipyard Limited 0.98%
LESS THAN 0.75% EXPOSURE 1.26%
FUTURES LONG POSITION 0.83%
Hindustan Aeronautics Limited 0.83%
TOTAL EQUITY HOLDING 97.12%
FIXED INCOME HOLDINGS Rating % of Net Assets
Treasury Bill 1.72%
364 Days Tbill (MD 04/02/2027) SOV 1.72%
Total Fixed Income Holdings 1.72%
TREPS, Cash & Other Net Current Assets 1.16%
GRAND TOTAL 100.00%

Investment in Top 10 scrips constitutes 44.15% of the portfolio


For SIP Performance please click here

For Scheme Performance please click here

The scheme currently does not have Distribution History

BER - Regular Plan (%) 1.95%
BER - Direct Plan (%) 0.98%
Portfolio Turnover Ratio 0.53

The Total Expense Ratio (TER) is the sum of the Base Expense Ratio (BER), brokerage fees, transaction costs, and statutory levies.
For details of TER, please refer the TER disclosure available on the website on https://www.barodabnpparibasmf.in/downloads/total-expense-ratio-of-mutual-fund-schemes.

No of Stocks 44
Portfolio RoE (%) 16.80
EPS Growth (%) 29.45

This product is suitable for investors who are seeking*:

➤ Long term capital appreciation.
➤ Investing in equity and equity related securities of companies engaged in manufacturing theme.

*Investors should consult their nancial advisers if in doubt about whether the product is suitable for them.

Scheme Riskometer^^
Investors understand that their principal will be at Very High risk


Benchmark (Tier 1) Riskometer^
Benchmark riskometer is at Very High risk


^^Riskometer For Scheme: basis it’s portfolio, ^Riskometer For Benchmark (Nifty India Manufacturing TRI): basis it’s constituents; As on July 31, 2026

For complete portfolio, kindly refer the website https://www.barodabnpparibasmf.in/
* refer Glossary page

Mutual Fund investments are subject to market risks, read all scheme related documents carefully.